An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II

por Chelouah, Sonia, Monod-Wissler, Caroline, Bailly, Christian, Barret, Jean-Marc, Guilbaud, Nicolas, Vispé, Stéphane, Käs, Emmanuel
Publicado 2011

Spatial and Temporal Dynamics of Mass Mortalities in Oysters Is Influenced by Energetic Reserves and Food Quality

por Pernet, Fabrice, Lagarde, Franck, Jeannée, Nicolas, Daigle, Gaetan, Barret, Jean, Le Gall, Patrik, Quere, Claudie, D’orbcastel, Emmanuelle Roque
Publicado 2014

ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells

por Le Clorennec, Christophe, Lazrek, Yassamine, Dubreuil, Olivier, Sampaio, Carla, Larbouret, Christel, Lanotte, Romain, Poul, Marie-Alix, Barret, Jean-Marc, Prost, Jean-François, Pèlegrin, André, Chardès, Thierry
Publicado 2019

Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cel...

por Prat, Mélissa, Salon, Marie, Allain, Thibault, Dubreuil, Olivier, Noël, Grégory, Preisser, Laurence, Jean, Bérangère, Cassard, Lydie, Lemée, Fanny, Tabah-Fish, Isabelle, Pipy, Bernard, Jeannin, Pascale, Prost, Jean-François, Barret, Jean-Marc, Coste, Agnès
Publicado 2021

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages

por Bougherara, Houcine, Némati, Fariba, Nicolas, André, Massonnet, Gérald, Pugnière, Martine, Ngô, Charlotte, Le Frère-Belda, Marie-Aude, Leary, Alexandra, Alexandre, Jérôme, Meseure, Didier, Barret, Jean-Marc, Navarro-Teulon, Isabelle, Pèlegrin, André, Roman-Roman, Sergio, Prost, Jean-François, Donnadieu, Emmanuel, Decaudin, Didier
Publicado 2017

The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer

por Barret, Jean-Marc, Nicolas, André, Jarry, Anne, Dubreuil, Olivier, Meseure, Didier, Passat, Tilda, Perrial, Emeline, Deleine, Cécile, Champenois, Gabriel, Gaillard, Solenne, Duchalais, Emilie, Ray-Coquard, Isabelle, Lahmar, Mehdi, Dumontet, Charles, Bennouna, Jaafar, Bossard, Céline, Roman-Roman, Sergio, Prost, Jean-François
Publicado 2021

Circulating CD14(high) CD16(low) intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

por Prat, Mélissa, Le Naour, Augustin, Coulson, Kimberley, Lemée, Fanny, Leray, Hélène, Jacquemin, Godefroy, Rahabi, Mouna Chirine, Lemaitre, Léa, Authier, Hélène, Ferron, Gwenaël, Barret, Jean-Marc, Martinez, Alejandra, Ayyoub, Maha, Delord, Jean-Pierre, Gladieff, Laurence, Tabah-Fisch, Isabelle, Prost, Jean-François, Couderc, Bettina, Coste, Agnès
Publicado 2020

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

por Estupina, Pauline, Fontayne, Alexandre, Barret, Jean-Marc, Kersual, Nathalie, Dubreuil, Olivier, Le Blay, Marion, Pichard, Alexandre, Jarlier, Marta, Pugnière, Martine, Chauvin, Maëva, Chardès, Thierry, Pouget, Jean-Pierre, Deshayes, Emmanuel, Rossignol, Alexis, Abache, Toufik, de Romeuf, Christophe, Terrier, Aurélie, Verhaeghe, Lucie, Gaucher, Christine, Prost, Jean-François, Pèlegrin, André, Navarro-Teulon, Isabelle
Publicado 2017